# Major Recall Alert: Amoxivue Recalled in Nigeria Due to Low Active Ingredient Levels
Consumers in Nigeria are being urged to take caution following a significant product recall of **Amoxivue Amoxicillin 500mg Capsules**. The recall was announced by Nigeria's National Agency for Food and Drug Administration and Control (NAFDAC) after discovering that the medication contained **significantly low levels of its active pharmaceutical ingredient (API)**. This deficiency poses potential health risks as the product may fail to adequately treat bacterial infections.
Learn the full details of this recall and how to ensure your safety amid growing health concerns.
---
## Why This Recall is Important
When medications do not contain adequate levels of their active ingredient, they may fail to work as intended. In the case of **Amoxivue Amoxicillin 500mg Capsules**, insufficient API levels could lead to:
- Ineffective treatment of bacterial infections
- Increased risk of antibiotic resistance
- Prolonged illness or complications from untreated infections
Such issues could compromise public health, making it critical for affected consumers to act immediately.
---
## Details of the Recall
Below is an essential breakdown of the recall:
- **Category**: Medications (Antibiotics)
- **Brand**: Amoxivue
- **Product Name**: Amoxicillin 500mg Capsules
- **Reason for Recall**: Product contains **significantly reduced levels of the active pharmaceutical ingredient (API)**, rendering it ineffective for treating bacterial infections.
- **Date Announced**: October 2023
- **Authority Involved**: National Agency for Food and Drug Administration and Control (NAFDAC)
- **Official Notice**: [NAFDAC Public Alert No. 025/2025](https://nafdac.gov.ng/public-alert-no-025-2025-recall-of-amoxivue-amoxicillin-500mg-capsules-due-to-significantly-low-active-pharmaceutical-ingredient-api-content/)
NAFDAC is urging the public to stop using Amoxivue capsules immediately and follow their guidelines for the return or disposal of affected products.
---
## What You Should Do
If you have recently purchased or consumed **Amoxivue Amoxicillin 500mg Capsules**, here’s what you need to do:
1. **Stop Using the Product Immediately**: Discontinue use of the capsules to prevent potential health risks.
2. **Check Your Supply**: Verify whether your medication is part of the recall by checking the packaging details or contacting a medical professional.
3. **Contact Your Healthcare Provider**: If you’re currently being treated with this medication, consult your doctor to discuss alternatives for your treatment.
4. **Return Affected Products**: Follow NAFDAC’s specific instructions for returning or safely disposing of the recalled capsules.
For more guidance, contact **NAFDAC** or your local healthcare facility. Acting quickly could prevent the risks associated with using ineffective medications.
---
## Stay Safe – Get Instant Recall Alerts
Consumer safety is a priority, especially when it comes to products like medications. Stay up to date on important recall alerts by downloading our **product recall notification app**!
With the app, you’ll:
- Receive **real-time recall alerts** for medications, food, and consumer products.
- Access detailed safety information to protect your family.
- Ensure compliance with local health guidelines.
Don’t take risks with your health and safety – [**Download the Recall Alert App Now**](#).
---
The recall of **Amoxivue Amoxicillin 500mg Capsules** reinforces the need for vigilance when it comes to product safety. Stay informed by regularly checking for updates from credible sources like NAFDAC. Together, we can help ensure public health and safety.
For the official recall notice, visit [NAFDAC’s website here](https://nafdac.gov.ng/public-alert-no-025-2025-recall-of-amoxivue-amoxicillin-500mg-capsules-due-to-significantly-low-active-pharmaceutical-ingredient-api-content/).